Atlas Trials

AstraZeneca

3,472 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch AstraZeneca

RecordFirmDate
Effects of AZD1775 on the PK Substrates for CYP3A, CYP2C19, CYP1A2 and on QT Interval in Patients With Advanced Cancer (NCT03333824)AstraZeneca2017-12-01
Comparative Effectiveness of Cardiovascular Outcomes in New Users of SGLT-2 Inhibitors (NCT02993614)AstraZeneca2017-11-30
Study to Determine if AZD0284 is Effective and Safe in Treating Plaque Psoriasis (NCT03310320)AstraZeneca2017-11-29
Study to Evaluate Tezepelumab in Adults & Adolescents With Severe Uncontrolled Asthma (NCT03347279)AstraZeneca2017-11-23
A Study to Evaluate the Symptoms Over 24 Hours in Patients With Chronic Obstructive Pulmonary Disease - LASSYC Study (NCT03381560)AstraZeneca2017-11-07
Safety Of DAPAGLIFLOZIN (FORXIGA) in Patient With Type 2 Diabetes Mellitus (T2dm) In Vietnam From A Post-Marketing Surveillance Program (NCT07210307)AstraZeneca2017-10-31
AZD5718 Phase IIa Study to Evaluate Efficacy, Safety and Tolerability of Oral AZD5718 in Patients With Coronary Artery Disease (CAD). (NCT03317002)AstraZeneca2017-10-30
A Study to Assess Therapeutic Equivalence Between Test EMLA Patch With Marketed EMLA Patch in Healthy Subjects. (NCT03313336)AstraZeneca2017-10-30
AZD1775 Continued Access Study to Assess Safety and Tolerability for Patients Enrolled in AZD1775 Clinical Pharmacology Studies (NCT03313557)AstraZeneca2017-10-27
A Study to Assess the Effect of Intensive Uric Acid (UA) Lowering Therapy With RDEA3170, Febuxostat, Dapagliflozin on Urinary Excretion of UA (NCT03316131)AstraZeneca2017-10-25
Study to Assess Safety, Tolerability, Pharmacokinetics and Antitumor Activity of AZD4573 in Relapsed/Refractory Haematological Malignancies (NCT03263637)AstraZeneca2017-10-24
A Safety and Pharmacodynamic Study of Healthy Chinese Subjects Administered Sodium Zirconium Cyclosilicate (ZS) (NCT03283267)AstraZeneca2017-10-24
Resistance & Activating Mutations Diagnosed Among NSCLC Community Dwelling EGFR Mutation Positive Patients (NCT03137264)AstraZeneca2017-10-24
Assessment of Asthma Control Level in Primary Care Setting in Malaysia (NCT03804632)AstraZeneca2017-10-23
Study to Evaluate Safety and Efficacy of Dapagliflozin and Saxagliptin in Patients With Type 2 Diabetes Mellitus (T2DM) Aged 10 to Below 18 Years Old (NCT03199053)AstraZeneca2017-10-11
Study of Durvalumab and Tremelimumab as First-line Treatment in Patients With Advanced Hepatocellular Carcinoma (NCT03298451)AstraZeneca2017-10-11
Study to Compare the Effects of AZD9496 vs Fulvestrant in Breast Cancer. (NCT03236974)AstraZeneca2017-10-05
Phase I Study to Assess the Effect of Food on AZD1775 Pharmacokinetics in Patients With Advanced Solid Tumours (NCT03315091)AstraZeneca2017-09-29
The Purpose of the Study is to Compare Two Fixed Dose Combination Tablets of Dapagliflozin/Metformin XR in Healthy Subjects Under Fasting and Fed Conditions (NCT03216278)AstraZeneca2017-09-26
A Multi-centre, Prospective, Observational Study on Effectiveness and Safety of ZOLADEX® (Goserelin Acetate Implant) 10.8 mg and ZOLADEX® (Goserelin Acetate Implant) 3.6 mg in Chinese Patients With Localized or Locally Advanced Hormonal Treatment -naïve Prostate Cancer (NCT03193060)AstraZeneca2017-09-19
A Study to Investigate Biomarker Effects of Pre-Surgical Treatment With DNA Damage Repair (DDR) Agents in Patients With Head and Neck Squamous Cell Carcinoma (HNSCC). (NCT03022409)AstraZeneca2017-09-18
Retrospective Study to Describe Prevalence of Hyperkalemia in Russian Population Based on Large Laboratory Network (HEKATE) (NCT03657875)AstraZeneca2017-09-15
Efficacy and Safety Study of Benralizumab in Patients With Uncontrolled Asthma on Medium to High Dose Inhaled Corticosteroid Plus LABA (MIRACLE) (NCT03186209)AstraZeneca2017-09-07
A Study to Investigate the Effect of Single Dose of AZD6094 (600 mg) on Cardiac Repolarization in Healthy Volunteers (NCT03258515)AstraZeneca2017-09-06
Open-label Safety of Sodium Zirconium Cyclosilicate for up to 12 Months in Japanese Subjects With Hyperkalemia (NCT03172702)AstraZeneca2017-09-04
← Previous Next →

Track AstraZeneca automatically

Every clearance here is in the API, with alerts when new ones post.